Insung Information Co., Ltd

Insung Information Co., Ltd

KKRX:033230
1,049.00
KRW
+13.00
(+1.25%)
-61.83EPS
78.97BMarket Cap
Insung Information Co., Ltd
KRX:033230
(Korea Stock Exchange)

Recent

price

1,049.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
9,331.35
10,821.07
11,157.15
11,036.18
11,111
11,058.63
10,840.5
10,378.89
9,634.12
9,362.87
7,857.8
6,456.78
7,569.5
8,594.51
8,082.78
6,840.79
7,111.22
Revenue per Share
214.87
167.36
104.22
305.53
-147.05
-451.15
47.83
-152.05
-16.42
-14.99
-216.3
24.36
28.11
-6.56
-190
-67
-28.4
Basic EPS, GAAP
-228.97
-34.44
-425.05
48.42
-237.64
-625.73
543.42
83.73
-416.66
-37.64
466
-166.08
-719.76
-226.75
316.2
412.13
-28.48
Free Cash Flow per Basic Share
- -
- -
7.36
5.26
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1,273.51
1,691.18
1,820.88
2,107.04
1,905.33
1,442.64
1,489.64
1,627.13
1,521.98
1,458.8
1,633.09
1,753.54
1,790.42
1,767.7
1,756.11
1,738.34
1,707.83
Book Value per Share
1,238.82
1,572.48
1,729.35
2,003.47
1,799.4
1,330.98
1,393.2
1,550.39
1,452.35
1,398.04
1,578.23
1,710.66
1,735.71
1,699.11
1,708.05
1,705.65
1,676.47
Tangible Book Value per Share
23
23
23
23
23
23
23
25
27
26
31
40
42
42
44
50
50
Basic Weighted Avg Shares
215,948
250,815
258,634
255,647
257,419
256,519
252,677
255,836
258,033
246,656
241,993
258,308
314,506
365,241
359,587
342,738
356,323
Sales/Revenue/Turnover
2.59
3.41
1.42
2.73
1.21
-1.22
1.96
1.22
1.2
1.4
1.25
0.77
0.93
1.44
-1.31
-1.25
-0.71
Operating Margin (%)
1,133
1,262
1,498
1,517
1,559
1,757
703
1,486
1,158
1,599
1,554
2,022
3,208
3,072
3,262
2,857
2,719
Depreciation Expense
4,972
3,879
2,416
7,077
-3,407
-10,465
1,115
-3,748
-440
-395
-6,661
975
1,168
-279
-8,453
-3,357
-1,423
Net Income, GAAP
27.99
28.07
37.45
- -
- -
- -
41.31
- -
355.51
193.4
- -
46.03
35.2
- -
- -
- -
- -
Effective Tax Rate (%)
2.3
1.55
0.93
2.77
-1.32
-4.08
0.44
-1.46
-0.17
-0.16
-2.75
0.38
0.37
-0.08
-2.35
-0.98
-0.4
Profit Margin (%)
23,449
21,296
27,783
32,381
31,748
37,824
23,022
32,531
36,535
38,342
33,093
58,924
57,107
76,047
84,026
63,080
63,005
Working Capital
3,137
1,500
1,900
927
520
19,115
2,480
3,963
10,297
14,108
4,818
9,147
4,104
25,572
21,632
2,256
2,065
LT Debt
31,219
41,096
44,136
50,286
45,635
34,447
35,592
43,786
41,188
39,550
45,497
74,408
76,438
75,861
89,036
88,223
86,330
Total Equity
6.03
7.55
2.64
- -
- -
- -
2.94
- -
-8.47
-3.26
- -
1.05
1.69
- -
- -
- -
- -
Return on Invested Capital (%)
10.18
7.66
4.99
- -
- -
- -
2.52
- -
-7.96
-2.89
- -
1.87
2.55
- -
- -
- -
- -
Return on Capital (%)
17.65
11.29
5.94
15.54
-7.32
-26.95
3.28
-9.7
-1.06
-1.01
-16.13
1.67
1.59
-0.38
-10.49
-3.83
-1.67
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
20,334
20,570
18,552
LT Borrowings
3,135
1,910
1,721
LT Finance Leases
486
346
345
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
50
50
Market Capitalization
99,112
89,892
78,969

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
162,410
191,249
187,916
Cash, Cash Equivalents & STI
28,122
41,686
27,203
Accounts Receivable, Net
55,510
77,468
67,812
Inventories
46,981
37,060
53,223
Total Current Liabilities
98,915
128,169
124,911
Payables & Accruals
- -
- -
- -
ST Debt
20,334
20,570
18,552
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.35%
16.4%
-0.91%
Free Cash Flow
-261.33%
-12.64%
46.78%
Net Income, GAAP
359.49%
530.69%
-60.29%
Sales/Revenue/Turnover
3.27%
7.68%
-4.69%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
73,819
83,791
84,973
117,004
359,587
2025
60,990
75,158
80,534
126,055
342,738
2026
74,575
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-85.27
-71
-17
-14.67
-190
2025
-67
-69.35
2.8
66.83
-67
2026
-28.69
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Insung Information Co., Ltd. is a South Korea-based information technology (IT) solutions and services provider specializing in enterprise IT infrastructure, cloud computing, systems integration, and digital healthcare technologies. Founded in 1992 and headquartered in Seoul, South Korea, the company operates across key business segments including IT Infrastructure Solutions, Managed Services, IT Distribution, and Smart Healthcare. Its core product and service offerings comprise data center and cloud architecture solutions, including hyper-converged infrastructure (HCI), software-defined storage (SDS), and hybrid cloud orchestration; enterprise networking and security solutions, encompassing software-defined access (SD-Access), software-defined wide area networking (SD-WAN), and perimeter protection; collaboration and unified communications systems, including contact center infrastructure, enterprise voice, and video conferencing platforms; IT managed services and system integration, delivered through its proprietary machine learning-driven operations management platform, AZit; specialized embedded engineering solutions for defense, aerospace, power generation, and semiconductor manufacturing sectors; high-performance computing (HPC) and networking hardware distribution via its subsidiary iNetBank; and digital healthcare solutions, featuring Hicare remote patient monitoring (RPM) platforms, chronic care management (CCM) devices, and the OK DOC cross-border telemedicine platform. In recent developments, Insung Information has accelerated its strategic transition toward artificial intelligence transformation (AX) and recurring cloud-native managed services, expanding high-performance AI infrastructure deployment and integrating generative AI capabilities into its OK DOC healthcare consultation platform. Supported by capital increases backed by major shareholder S-Net Systems, the company has broadened its global healthcare operations through its specialized subsidiary Hicarenet, scaling remote care programs with the United States Department of Veterans Affairs (VA) and developing AI-powered diagnostic solutions for respiratory and neurodegenerative conditions. The company serves corporate, public sector, and medical clients across South Korea, North America, Europe, and Asia.